Clinical Trials Browser

Phase 2 × Glioblastoma × montanide ISA 51 × Clear all

NCT02455557 2026-02-25

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Phase 2 Active not recruiting

66 enrolled 11 charts

Glioblastoma, Gliosarcoma

NCT04013672 2024-08-28

Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence

Phase 2 Completed

41 enrolled 15 charts

Glioblastoma